These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 28806935)

  • 1. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
    Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
    BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
    Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
    Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection.
    Wang CY; Lin YS; Tzao C; Lee HC; Huang MH; Hsu WH; Hsu HS
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):877-81. PubMed ID: 17920921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
    Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
    Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in older patients with advanced non-small cell lung cancer in China.
    Su Q; Sun YP; Liu YH; Li Z; Yang HY; Sun ZG; Cao BW; Jia JH
    Tumori; 2014; 100(1):69-74. PubMed ID: 24675494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
    Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
    Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
    Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
    Singh N; Singh PS; Aggarwal AN; Behera D
    Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced non-small cell lung cancer in the elderly: the impact of age and comorbidities on treatment modalities and patient prognosis.
    Hsu CL; Chen JH; Chen KY; Shih JY; Yang JC; Yu CJ; Yang PC
    J Geriatr Oncol; 2015 Jan; 6(1):38-45. PubMed ID: 25245172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients.
    Boros A; Lacroix L; Lacas B; Adam J; Pignon JP; Caramella C; Planchard D; de Montpreville V; Deutsch E; Levy A; Besse B; Le Pechoux C
    Oncotarget; 2017 Apr; 8(15):25189-25199. PubMed ID: 28445990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non-Small Cell Lung Cancer.
    Bott MJ; Patel AP; Crabtree TD; Morgensztern D; Robinson CG; Colditz GA; Waqar S; Kreisel D; Krupnicka AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Jun; 99(6):1921-8. PubMed ID: 25912748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor.
    Irisa K; Masago K; Togashi Y; Fujita S; Hatachi Y; Fukuhara A; Sakamori Y; Kim YH; Mio T; Mishima M
    Med Oncol; 2012 Mar; 29(1):185-92. PubMed ID: 21136210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer.
    Moro-Sibilot D; Aubert A; Diab S; Lantuejoul S; Fourneret P; Brambilla E; Brambilla C; Brichon PY
    Eur Respir J; 2005 Sep; 26(3):480-6. PubMed ID: 16135732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
    Chen KY; Chen JH; Shih JY; Yang CH; Yu CJ; Yang PC
    J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol abuse predicts progression of disease and death in patients with lung cancer.
    Paull DE; Updyke GM; Baumann MA; Chin HW; Little AG; Adebonojo SA
    Ann Thorac Surg; 2005 Sep; 80(3):1033-9. PubMed ID: 16122481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.